uk Modifications in Central Hemodynamics Due to Intermittent Pneumatic Compression Effects on the Lymphatic System

Main Article Content

Andriy Leonidovych Palamarchuk
Daryna Volodymyrivna Shesterina

Abstract

High prevalence of cardiovascular diseases, [1] implies continuous
improvement of noninvasive physical techniques particularly perfectioning of compression therapy
techniques, [3]. Intermittent pneumatic compression (IPC) widely used thought multipurpose physical
rehabilitation in vascular surgery, dermatologic surgery, and sport medicine. Compression therapy
(CT) is an established treatment method with very low rate of complications in research various facets
of vascular and skeletal muscle physiology, [4].

Article Details

Section
Статті
Author Biographies

Andriy Leonidovych Palamarchuk, Kyiv Medical University

candidate of medical sciences, associate professor Kyiv Medical University

Daryna Volodymyrivna Shesterina, Cherkasy National University named after Bohdan Khmelnytskyi

graduate student of the Department of Anatomy, Physiology and Physical Rehabilitation Cherkasy National University named after B. Khmelnytskyi

References

Alzubaidi N.H., Jackson J.K. Cardiovascular disease as a leading cause of death. Journal of Integrated

Pharmacy. 2019.P.1–11.

Berszakiewicz A. Compression therapy in venous diseases. Journal of Advances in Dermatology and

Allergology. 2020. P.836-840.

Tarshinova L., Yelchyts Т. Volumetric pneumopressing in treating of limb lymphedema. Collection of scientific

works of staff members of NMAPE. Institute for Health care Technologies “New in Medicine”. 2015. P.23-38.

Kyoungrae K. Neither Peristaltic Pulse Dynamic Compressions nor Heat Therapy Accelerate Glycogen

Resynthesis after Intermittent Running. Journal of medical science sports exercises. 2021. P.2425-2435.

Zaytsev D.V. About the mechanism of volumetric pneumopressing action. Collection of scientific works of staff

members of NMAPE. Institute for Health care Technologies “New in Medicine”. 2015.P.47-78.

Taradaj J. Comparison of efficacy of the intermittent pneumatic compression with a high- and low-pressure

application in reducing the lower limbs phlebolymphedema the clinical risk management. J Physiol. 2015.

P.1545–1554.

Bergmann A. Conservative treatment of lymphedema: the state of the art. Journal Vascular Brasileiro. 2022.

P.1677-5449.

Wall J. A pilot study of venous flow augmentation using a novel mechanical graded. Journal Clinical research

study compession therapy for chronic venous disease volume7, issue2.2019. P.217-221.

Hyun Beom K. Investigation of Blood Flow During Intermittent Pneumatic Compression. Journal Clin Appl

Thromb Hemost.2018. P.1324-1354.

Rhys J. Haematological Effects of Intermittent Pneumatic Compression for Deep Vein Thrombosis Prophylaxis.

J Physiol.2020. P.912-923.

Dai G. An in vitro cell culture system to study the influence of external pneumatic compression on endothelial

function. Journal of Vascular Surgery, № 32. 2002. P. 977- 987.

Mridha M. Fluid translocation measurement. Journal а method to study pneumatic compression treatment of

postmastectomy lymphedema.1989. P.63-69.

Schwahn-Schreiber C. S1-Leitlinie Intermittierende Pneumatische Kompression (IPK, AIK) Der

Hautarzt volume 69. Journal Biomed .2018. P.662–673.

Darne C. Direct evidence of lymphatic function improvement after advanced pneumatic compression device

treatment of lymphedema. Journal Biomed.2010. P.114-125.

Kohro S. Intermittent pneumatic foot compression can activate blood fibrinolysis without changes in blood

coagulability and platelet activation. Journal Acta Anaesthesiologica Scandinavica.2005. P.660-664.

Fopiano A. Role of Caveolae in the Development of Microvascular Dysfunction and Hyperglycemia in Type 2

Diabetes. Journal Fronties Physiology.2022. P.13-18.